Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental situation

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● The opinion of analysts covering the stock has improved over the past four months.


Weaknesses

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● With an expected P/E ratio at 138 and 79.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● In relation to the value of its tangible assets, the company's valuation appears relatively high.

● The company is highly valued given the cash flows generated by its activity.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Over the past twelve months, analysts' opinions have been revised negatively.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.